| Vividion Gets $135M in Collaboration With Roche on Protein Degradation | Sarah de Crescenzo | 05/20/20 | San Diego |
| Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic | Sarah de Crescenzo | 04/01/20 | San Diego |
| Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs? | Ben Fidler | 06/13/19 | San Francisco |
| Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic | Sarah de Crescenzo | 04/30/19 | San Diego |
| Down the Stretch: Akcea, Alnylam Face Reality Checks as FDA Dates Loom | Alex Lash | 07/06/18 | Boston |
| If Budget Holds, NIH Precision Study Could Be Flush As Volunteers Arrive | Alex Lash | 05/04/17 | National |
| At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills | Ben Fidler | 02/27/17 | Boston |
| As U.S. Looks to Launch Precision Health Study, Google’s Role Emerges | Alex Lash | 08/11/16 | National |
| Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More | Ben Fidler | 06/24/16 | National |
| Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M | Ben Fidler | 03/23/16 | Boston |
| West Coast Bio Roundup: Shkreli, BlackThorn, Unhappy Holiday Layoffs | Alex Lash | 12/24/15 | San Francisco |
| Diagnostic-Maker Scanadu Lands $35M As FDA Submission Nears | David Holley | 04/27/15 | San Francisco |
| Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M | Ben Fidler | 12/18/14 | Boston |
| West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More | Alex Lash | 08/14/14 | San Francisco |
| Seattle’s KinDex Gets $5M to Fight Diabetes, Burn Fat With Hops | Ben Fidler | 03/25/14 | Seattle |
| With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs | Bernadette Tansey | 02/25/13 | Boston |
| Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News | Erin Kutz | 05/07/10 | Boston |
| CareFusion Hits Acquisition Trail, Cadence Pharmaceuticals Enlists Manufacturing Expertise, Medsphere Systems Sees Explosion in Bookings, & More San Diego Life Sciences News | Denise Gellene | 04/08/10 | San Diego |
| Carl Icahn Nominates Three More Candidates for Biogen Board Seats | Ryan McBride | 01/28/10 | Boston |
| Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology | Luke Timmerman | 09/30/09 | National |
| How to Build a Billion-Dollar Company (And Keep An Academic Day Job), According to David Walt | Luke Timmerman | 08/31/09 | National |
| Biogen Idec Pipeline Strong, Tysabri Coming Back; Icahn Would “Weaken” Board, Company Says | Luke Timmerman | 05/14/09 | Boston |
| West Wireless Health Institute Established With $45M Donation | Juha-Pekka Tikka | 03/30/09 | San Diego |
| ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News | Rebecca Zacks | 03/11/09 | Boston |
| Stemgent Nails Down $14M to Make Supplies, Tools for Stem Cell Researchers | Luke Timmerman | 03/09/09 | Boston |
| New Pfizer Incubator Chief Looks Far and Wide for New Science, But Backs Off Plans for Boston Site | Ryan McBride | 10/14/08 | San Diego |
| ProteoStasis Takes Off From $45 Launch Pad, BitWave Receives $10M Transmission, GameLogic Reckons $8M Will Do, & More Deals News | Rebecca Zacks | 08/25/08 | Boston |
